Original Research Nano-adjuvanted polio vaccine: Preparation and characterization of chitosan and trimethylchitosan (TMC) nanoparticles loaded with inactivated polio virus and coated with sodium alginate

Publish Year: 1393
نوع سند: مقاله ژورنالی
زبان: English
View: 264

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_NAMJ-1-4_002

تاریخ نمایه سازی: 18 تیر 1398

Abstract:

Objective(s):  It is proposed that particulate antigens could better interact with the antigen presenting cells (APCs). A fast, simple and scalable process for preparation of polymeric nanoparticles (NPs) is coating of charged antigenic particles, like viruses, with oppositely charged polymers. A second coating with a charged polymer could increase the stability and modify the immunomodulatory potentials of NPs.  Materials and Methods:  Negatively charged inactivated polio virus (IPV) was coated with cationic polymers, chitosan (CHT) and trimethylchitosan (TMC) by a simple incubation method. CHT: IPV and TMC: IPV NPs were coated by anionic polymer, sodium alginate (ALG). Physical characteristics and stability of NPs were studied. Cytocompatibility of NPs was checked with MTT assay. DC maturation study was used for evaluation of the NPs potential in interaction with DCs.  Results:  Among the various polymer to antigen ratios tested, the least size and PDI and the highest ZP was seen in TMC: IPV (2:1), CHT: IPV (2:1), ALG: TMC: IPV (2:2:1) and ALG: CHT: IPV (4:2:1). The physical stability of TMC: IPV and CHT: IPV was preserved until 15 days. After an early de-association of some part of coated alginate, ALG: CHT: IPV and ALG: TMC: IPC NPs were stable until the end of study (25th day). No one of the NPs formulations had a negative effect on cell viability. Compared with plain IPV, nanoparticulate IPV formulations failed to increase the expression of CD40 and CD86 markers of DCs.  Conclusion:   NPs prepared with simple and scalable method, had reasonable physical characteristics, stability and cytocompatibility and could be tested in vivo for their immunoadjuvant potential.

Authors

Mohsen Tafaghodi

Nanotechnology Research Center, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran | Division of Drug Delivery Technology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, Netherlands

Gideon Kersten

Division of Drug Delivery Technology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, Netherlands | Institute for Translational Vaccinology, Bilthoven, Netherlands

Wim Jiskoot

Division of Drug Delivery Technology, Leiden Academic Centre for Drug Research, Leiden University, Leiden, Netherlands

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Amorij JP, Hinrichs W, Frijlink HW, Wilschut JC, Huckriede A. ...
  • Saluja V, Amorij JP, van Roosmalen ML, et al. Intranasal ...
  • Tafaghodi M, Rastegar S. Preparation and in vivo study of ...
  • Amin M, Jaafari MR, Tafaghodi M. Impact of chitosan coating ...
  • Slutter B, Hagenaars N, Jiskoot W. Rational design of nasal ...
  • Hirschberg HJHB, de Wijdeven GGPv, Kraan H, Amorij J-P, Kersten ...
  • Hagenaars N, Mastrobattista E, Verheul RJ, et al. Physicochemical and ...
  • Tafaghodi M, Saluja V, Kersten GF, et al. Hepatitis B ...
  • Koping-Hoggard M, Sanchez A, Alonso MJ. Nanoparticles as carriers for ...
  • Almeida AJ, Alpar HO. Mucosal immunization with antigen-containing microparticles. In: ...
  • Verheul RJ, Amidi M, van der Wal S, van Riet ...
  • Mangal S, Pawar D, Garg NK, et al. Pharmaceutical and ...
  • Bal SM, Ding Z, van Riet E, Jiskoot W, Bouwstra ...
  • Illum L, Jabbal-Gill I, Hinchcliffe M, Fisher AN, Davis SS. ...
  • van der Lubben IM, Kersten G, Fretz MM, Beuvery C, ...
  • Amidi M, Mastrobattista E, Jiskoot W, Hennink WE. Chitosan-based delivery ...
  • Boonyo W, Junginger HE, Waranuch N, Polnok A, Pitaksuteepong T. ...
  • Sadeghi AM, Dorkoosh FA, Avadi MR, Saadat P, Rafiee-Tehrani M, ...
  • Amidi M, Romeijn SG, Borchard G, Junginger HE, Hennink WE, ...
  • Amidi M, Romeijn SG, Verhoef JC, et al. N-Trimethyl chitosan ...
  • Hagenaars N, Verheul RJ, Mooren I, et al. Relationship between ...
  • Slutter B, Bal S, Keijzer C, et al. Nasal vaccination ...
  • Slutter B, Plapied L, Fievez V, et al. Mechanistic study ...
  • Demoulins T, Bassi I, Thomann-Harwood L, et al. Alginate-coated chitosan ...
  • Oliveira CR, Rezende CM, Silva MR, Pego AP, Borges O, ...
  • Bal SM, Slutter B, van Riet E, et al. Efficient ...
  • Hagenaars N, Mania M, de Jong P, et al. Role ...
  • (28) Muzzarelli RA. Colorimetric determination of chitosan. Anal Biochem. 1998; ...
  • (29) Wischke C, Borchert HH. Increased sensitivity of chitosan determination ...
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: ...
  • Jafari T, Simchi A, Khakpash N. Synthesis and cytotoxicity assessment ...
  • De Jong EC, Vieira PL, Kalinski P, et al. Microbial ...
  • Bal SM, Slutter B, van Riet E, et al. Efficient ...
  • Borges O, Borchard G, Verhoef JC, de Sousa A, Junginger ...
  • Borges O, Cordeiro-da-Silva A, Tavares J, et al. Immune response ...
  • Borges O, Silva M, de Sousa A, Borchard G, Junginger ...
  • Chen F, Zhang ZR, Huang Y. Evaluation and modification of ...
  • Zhou J, Romero G, Rojas E, Ma L, Moya S, ...
  • نمایش کامل مراجع